Scotland · NHS Scotland MSAN
NovoRapid® (insulin aspart) FlexTouch® 100units/ml solution for injection 3ml
MSAN(2024)63 · Level 2 · issued 22 Nov 2024
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| Valid until: product is being discontinued | Discontinued | — |
| pens are being discontinued; stock is anticipated to be exhausted by March 2025. | Discontinued | — |
| remain available and can support a full increase in demand. | Available | — |
| remain available and can support a full increase in demand. | Available | — |
| pens and 3ml cartridges) remain available and can support a full increase in demand. | Available | — |
| 5. TO NOTE: This is the first of three MSANs covering discontinuations with Novo Nordisk insulin | Discontinued | — |
| discontinuations and the wider supply availability of insulin. | Discontinued | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.